Doximity
The acquisition comes amid OpenEvidence's lawsuit alleging that Pathway Medical stole trade secrets, which Pathway has denied.
Also: Pear Therapeutics reported $2.7 million in revenue for its first quarter compared with $1.3 million in Q4 2021.
The acquisition will cost $53.5 million in cash, plus an earnout consideration of up to $24 million and around $5 million in stock to employees joining Doximity.
Also: Convey Health Solutions seeks $186 million in its NYSE debut.
The Dialer is HIPAA-compliant and doesn’t require any additional setup on the patient side.
Doximity will be able to tap into its physician network for staffing.
Also: Doximity updates its physician social network app; Apple announces $1 billion campus in Austin, Texas.